This article is more than 5 years old. Information may no longer be current.

Integra completes acquisition of multiple lower extremity offerings from Tornier

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Integra LifeSciences Holding Corporation recently announced it has completed its acquisition of the domestic rights to Tornier’s Salto Talaris and Salto Talaris XT ankle replacement offerings and Tornier’s Futura silastic toe replacement line.

“The addition of the Salto Talaris enhances our lower extremities product offering and accelerates our entry into the U.S. total ankle replacement market,” Nick Gallucci, the vice president and U.S. sales leader, Extremity Reconstruction for Integra, stated in a company release. “We are also pleased to welcome several key employees who will be joining Integra's commercial organization.”

Although further financial information is expected to be released by Integra on their third-quarter earnings conference call, the company expects adjusted earnings per share to be inconsequential during the first year.

Reference: http://investor.integralife.com/releasedetail.cfm?ReleaseID=934892.